IL18 and neoplasm: Interestingly, in 90% of MSI CRCs and 70% of MSS CRCs, an intense IL-18 immunostaining was observed in more than 50% of tumor cells, which was associated with a higher density of intraepithelial CD8+ and Tbet+ TIL (IEL-TIL).